Neuraminidase inhibitors for preventing and treating influenza in healthy adults
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsReporting bias in medical research - a narrative reviewNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisInterventions for preventing influenza: an overview of Cochrane systematic reviewsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reportsInterventions for preventing influenza: an overview of Cochrane systematic reviewsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisAmantadine and rimantadine for influenza A in children and the elderlyNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisWhat is the optimal therapy for patients with H5N1 influenza?Influenza vaccines: from surveillance through production to protection.Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.Decision making with regard to antiviral intervention during an influenza pandemicEconomic model for emergency use authorization of intravenous peramivir.Understanding the Influenza A H1N1 2009 PandemicEffects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reportsReducing uncertainty in managing respiratory tract infections in primary care.Clinical review: update of avian influenza A infections in humans.Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu).Look at all the evidence before stockpiling amantadine.InfluenzaHas Cochrane lost its way?
P2860
Q21090775-6FBE5376-C147-480A-9B2F-9E244176ABD8Q21203744-14DF9D9C-602E-42BE-B65F-ED5BE47B063CQ24186108-7BABC05E-ACCA-4295-802E-0EE0120D7BA5Q24193398-2C6D32A8-76EB-435B-906B-C7033C5E0942Q24200454-DF65DEE8-08B5-4F8A-B731-E4A3AFEEAF37Q24203905-21E6963B-BC6A-43A8-A516-222F9A7421E2Q24235164-16C684F5-0C72-4041-9477-D9A65880C9D7Q24235679-17DC2DE2-6E47-460E-AF03-E63EACC9E47CQ24236654-D2BEFD40-4E44-492A-97AE-CF1F3E94AFEFQ24240097-E98AE65B-5E97-49FE-A7A8-7A5F75DF8307Q24241128-A3894A81-91C9-41F9-A3B1-A9C27BC5DBC9Q24242639-C832E692-E617-4AF1-BBCC-CBA0A95AC742Q24644585-27BE8624-B930-45BA-8A8F-FAC71A31BDDEQ28475630-51F426DF-E0FF-4B20-B665-89AA405E02DBQ30385118-972C4E34-A782-4EA2-8258-9B91F446C00FQ30385821-1DF220F4-4BBF-40F6-A977-8FC89D9FFDE1Q30390834-59143F6E-116E-474A-AFF0-56C243689068Q30391440-292DE6AB-8A2A-47B3-9A97-8FCD66C29F3DQ30401754-A619FEC9-9C49-4B63-A98D-3D4FADEFC99CQ30402060-6B5A744B-01EE-4B9C-8857-D26C5B87BAC1Q33732457-B4472D99-FC82-450C-9187-5DCF5FF69DEAQ33776525-C9989603-DE45-4E14-BE82-9F46162692E2Q34264254-89D25C92-8BA7-4E7B-AC23-E60D18ED9A84Q34350110-A09B255C-7556-4F7A-A591-95688034F99CQ36392514-424A1D83-564B-42B5-A15E-1F3F1B6C1EACQ37017233-20A53A26-CEB3-46EB-BED9-D28919468228Q37247004-54D06E3C-90B7-4AB3-AD12-87283A6A7A8EQ40577440-806F7261-A182-4FC6-B8B7-341C51D788F7Q42926180-17E56602-72AF-430F-ADB3-F9DA61F992A8Q42942544-4E3ACCCD-0D82-4884-A0EF-1DD1A4BB3775Q57028463-1E566A13-9E77-4F93-A8AF-A8122D7778C7Q60603546-ed3887cf-43a7-7fd0-d049-2676fe2cecce
P2860
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@ast
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en-gb
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@nl
type
label
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@ast
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en-gb
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@nl
prefLabel
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@ast
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en-gb
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@nl
P2093
P2860
P3181
P1476
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
@en
P2093
Carl J Heneghan
Chris B Del Mar
Liz Dooley
Mark A Jones
Peter Doshi
Rokuro Hama
P2860
P3181
P356
10.1002/14651858.CD001265.PUB2
P577
2006-07-19T00:00:00Z